Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
AbCellera Biologics Inc. specializes in discovering and developing antibody-based medicines for diseases with high unmet needs. The company integrates advanced technology, data science, and automation to accelerate antibody drug discovery from target identification to clinical candidate delivery. Serving biotechnology and pharmaceutical partners primarily in the U.S. and Europe, AbCellera’s business model combines proprietary internal programs with strategic collaborations, generating value through milestone payments, royalties, and equity stakes.
This description was generated via AI from an annual report. Updated about 1 year ago.